X-154379496-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_000117.3(EMD):​c.12C>T​(p.Tyr4Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000437 in 1,168,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000062 ( 0 hom., 3 hem., cov: 26)
Exomes 𝑓: 0.000042 ( 0 hom. 16 hem. )

Consequence

EMD
NM_000117.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.796

Publications

0 publications found
Variant links:
Genes affected
EMD (HGNC:3331): (emerin) Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
EMD Gene-Disease associations (from GenCC):
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • heart conduction disease
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant X-154379496-C-T is Benign according to our data. Variant chrX-154379496-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 290626.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP7
Synonymous conserved (PhyloP=0.796 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0000616 (7/113652) while in subpopulation AFR AF = 0.000191 (6/31431). AF 95% confidence interval is 0.0000823. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EMDNM_000117.3 linkc.12C>T p.Tyr4Tyr synonymous_variant Exon 1 of 6 ENST00000369842.9 NP_000108.1 P50402

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EMDENST00000369842.9 linkc.12C>T p.Tyr4Tyr synonymous_variant Exon 1 of 6 1 NM_000117.3 ENSP00000358857.4 P50402

Frequencies

GnomAD3 genomes
AF:
0.0000528
AC:
6
AN:
113604
Hom.:
0
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000187
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000173
AC:
2
AN:
115306
AF XY:
0.0000253
show subpopulations
Gnomad AFR exome
AF:
0.000139
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000228
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000417
AC:
44
AN:
1054407
Hom.:
0
Cov.:
31
AF XY:
0.0000464
AC XY:
16
AN XY:
344827
show subpopulations
African (AFR)
AF:
0.0000804
AC:
2
AN:
24869
American (AMR)
AF:
0.00
AC:
0
AN:
28420
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18632
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
50055
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36890
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4058
European-Non Finnish (NFE)
AF:
0.0000488
AC:
40
AN:
819957
Other (OTH)
AF:
0.0000451
AC:
2
AN:
44348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000616
AC:
7
AN:
113652
Hom.:
0
Cov.:
26
AF XY:
0.0000838
AC XY:
3
AN XY:
35806
show subpopulations
African (AFR)
AF:
0.000191
AC:
6
AN:
31431
American (AMR)
AF:
0.00
AC:
0
AN:
10905
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3598
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2873
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6370
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000187
AC:
1
AN:
53362
Other (OTH)
AF:
0.00
AC:
0
AN:
1555
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000117
Hom.:
0
Bravo
AF:
0.0000567

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy Benign:1
Feb 06, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Jun 02, 2021
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

X-linked Emery-Dreifuss muscular dystrophy Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Oct 02, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

EMD-related disorder Benign:1
Jul 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
8.9
DANN
Benign
0.87
PhyloP100
0.80
PromoterAI
-0.12
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782011714; hg19: chrX-153607856; API